Disease Focus Area:
Solid Tumors
Targeting Solid Tumor Cancers
At BeOne Medicines our goal is to develop innovative medicines to address the unmet needs of large and broad populations worldwide. One of our key areas of research is solid tumor oncology.
Each year, more than 20 million new cancer cases are diagnosed worldwide;1 solid tumor cancers constitute more than 90% of all new cases of cancer.2 Solid tumors form when normal cells mutate and start growing uncontrollably, ignoring the body’s signals to stop dividing or die.2 As the tumor grows, it creates its own blood supply for nutrients, may eventually spread to other parts of the body and can find ways to avoid detection by the immune system, making it harder to eliminate.2
BeOne is working to develop potential first-in-class and best-in-class therapies for some of the most challenging solid tumor cancers, taking a disease-focused approach.
Our areas of focus include:
Gastrointestinal cancers
Lung cancers
Breast and gynecologic cancers
